The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells

Biochemical Pharmacology

Volumn 87, Issue 4, 2014, Pages 611-624

  Lennon, Jennifer C ^a,b   Bright, Sandra A ^a   Carroll, Eilis ^a   Butini, Stefania ^c   Campiani, Giuseppe ^c   O'Meara, Anne ^d   Williams, D Clive ^a   Zisterer, Daniela M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b National Children's Research Centre   (Ireland)

^c UNIVERSITY OF SIENA   (Italy)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Apoptosis; Carboplatin; Neuroblastoma; PBOX 6; Synergy

Indexed keywords

APOPTOSIS; CARBOPLATIN; NEUROBLASTOMA; PBOX-6; SYNERGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOPLATIN; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; NEUROBLASTOMA; OXAZEPINES; PYRROLES; UP-REGULATION;

EID: 84893766882     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.12.017     Document Type: Article

References (54)

1. J.M. Maris Recent advances in neuroblastoma N Engl J Med 362 2010 2202 2211
2. G.M. Brodeur, J. Pritchard, F. Berthold, N.L. Carlsen, V. Castel, and R.P. Castelberry et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment J Clin Oncol 11 8 1993 1466 1477 (Pubitemid 23228250)
3. K.K. Matthay, C.P. Reynolds, R.C. Seeger, H. Shimada, E.S. Adkins, and Haas-Kogan et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Children's Oncology Group study J Clin Oncol 2 7 2009 1007 1013
4. N. Keshelava, R.C. Seeger, S. Groshen, and C.P. Reynolds Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy Cancer Res 58 23 1998 5396 5405 (Pubitemid 28551122)
5. N. Keshelava, J.J. Zuo, N.S. Waidyaratne, T.J. Triche, and C.P. Reynolds p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma Med Pediatr Oncol 35 6 2000 563 568
6. N. Keshelava, S. Groshen, and C.P. Reynolds Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines Cancer Chemother Pharmacol 45 1 2000 1 8 (Pubitemid 30099708)
7. B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defence system Physiol Rev 86 2006 1179 1236 (Pubitemid 44521651)
8. H.S. Chan, G. Haddad, P.S. Thorner, G. DeBoer, Y.P. Lin, and N. Ondrusek et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma N Engl J Med 325 23 1991 1608 1614
9. J.M. Mulligan, L.M. Greene, S. Cloonan, M.M. Mc Gee, V. Onnis, and G. Campiani et al. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines Mol Pharmacol 70 1 2006 60 70
10. L.M. Greene, L. Kelly, V. Onnis, G. Campiani, M. Lawler, and D.C. Williams et al. STI-571 enhances the apoptotic efficacy of PBOX-6, a novel microtubule targeting agent, in both STI-571-sensitive and-resistant Bcr-Abl positive human chronic myeloid leukemia cells J Pharmacol Exp Ther 321 1 2007 288 297 (Pubitemid 46456968)
11. A.M. McElligott, E.N. Maginn, L.M. Greene, S. McGuckin, A. Hayat, and P.V. Browne et al. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine- 15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia Cancer Res 69 21 2009 8366 8375
12. S.M. Nathwani, S. Butler, D. Fayne, N. McGovern, B. Sarkadi, and M.J. Meegan et al. Novel microtubule targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug resistant (MDR) cancer cells Cancer Chemother Pharmacol 66 3 2010 585 596
13. S.A. Bright, L.M. Greene, T.F. Greene, G. Campiani, and S. Butini et al. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells Biochem Pharmacol 77 3 2007 310 321
14. S.A. Bright, G. Campiani, M.W. Deininger, M. Lawler, D.C. Williams, and D.M. Zisterer Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment Biochem Pharmacol 80 1 2010 31 38
15. E.N. Maginn, P.V. Browne, P. Hayden, E. Vandenberghe, B. MacDonagh, and P. Evans et al. PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells Br J Cancer 104 2 2011 281 289
16. L.M. Greene, S. Wang, N.M. O'Boyle, S.A. Bright, J.E. Reid, and P. Kelly et al. Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer Oncol Rep 29 6 2013 2451 2458
17. L.M. Greene, M. Fleeton, J. Mulligan, C. Gowda, B.J. Sheahan, and G.J. Atkins et al. The pyrrolo-1, 5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status, and inhibits breast tumour growth in vivo Oncol Rep 14 5 2005 1357 1363
18. G. Campiani, V. Nacci, I. Fiorini, M.P. De Filippis, A. Garofalo, and S.M. Ciani Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific 'peripheral-type' benzodiazepine receptor ligands J Med Chem 39 18 1996 3435 3450 (Pubitemid 26307848)
19. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
20. M. Wickström, J.I. Johnsen, F. Ponthan, L. Segerström, B. Sveinbjörnsson, and M. Lindskog et al. The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo Mol Cancer Ther 6 9 2007 2409 2417 (Pubitemid 47480406)
21. A.J. Dijkhuis, J. Douwes, W. Kamps, H. Sietsma, and J.W. Kok Differential expression of sphingolipids in P-glycoprotein or multidrug resistance-related protein 1 expressing human neuroblastoma cell lines FEBS Lett 548 1 2003 28 32 (Pubitemid 37281245)
22. B.J. Maurer, O. Kalous, D.W. Yesair, X. Wu, J. Janeba, and V. Maldonado Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex Clin Cancer Res 13 10 2007 May 15 3079 3086 (Pubitemid 46849585)
23. T. Kamei, M. Inui, S. Nakamura, K. Okumura, A. Goto, and T. Tagawa Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression Melanoma Res 13 2 2004 153 159 (Pubitemid 36583977)
24. E.H-Y. Cheng, D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, and A. Bedi et al. Conversion of bcl-2 to a bax death effector by caspases Science 278 5345 1997 1966 1968 (Pubitemid 28013242)
25. G. Dewson, and R.M. Kluck Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis J Cell Sci 122 Pt 16 2009 2801 2808
26. D.M. Zisterer, V. Campiani Nacci, and D.C. Williams Pyrrolobenzoxazepines induce apoptosis in HL-60, Jurkat and Hut-78 cells: a new class of apoptotic agents J Pharmacol Exp Ther 293 1 2000 48 59 (Pubitemid 30180922)
27. M.M. Mc Gee, G. Campiani, A. Ramunno, C. Fattorusso, V. Nacci, and M. Lawler et al. Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl J Pharmacol Exp Ther 296 1 2001 31 40 (Pubitemid 32015057)
28. H. Tong, C. Lu, Y. Yang, J. Zhang, and J. Zhang Role of caspase 8 as a determinant in trail sensitivity of neuroblastoma cell lines Pediatr Hematol Oncol 26 8 2009 549 559
29. S. Häcker, A. Dittrich, A. Mohr, T. Schweitzer, S. Rutkowski, and J. Krauss et al. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8 Oncogene 28 35 2009 3097 3110
30. D. Balayssac, A. Cayre, N. Authier, S. Bourdu, F. Penault-Llorca, and J.P. Gillet et al. Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats J Peripher Nerv Syst 10 3 2005 301 310 (Pubitemid 41580035)
31. R.A. Ross, J.L. Biedler, and B.A. Spengler A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors Cancer Lett 197 1-2 2003 9 35
32. M. Piacentini, L. Piredda, D.T. Starace, M. Annicchiarico-Petruzzelli, M. Mattei, and S. Oliverio et al. Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis J Pathol 180 4 1996 415 422 (Pubitemid 27014080)
33. N. Mohan, N.L. Banik, and S.K. Ray Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells Neurosci Lett 502 1 2011 24 29
34. H. Fang, T.M. Harned, O. Kalous, V. Maldonado, Y.A. DeClerck, and C.P. Reynolds Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma Clin Cancer Res 17 22 2011 7093 7104
35. R.J. Youle, and A. Strasser The BCL-2 protein family: opposing activities that mediate cell death Nat Rev Mol Cell Biol 9 1 2008 47 59
36. M. Dole, G. Nuñez, A.K. Merchant, J. Maybaum, C.K. Rode, C.A. Bloch, and V.P. Castle Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma Cancer Res 54 12 1994 3253 3259 (Pubitemid 24208938)
37. M.M. Mc Gee, L.M. Greene, S. Ledwidge, G. Campiani, V. Nacci, and M. Lawler et al. Selective induction of apoptosis by pyrrolo-1,5-benzoxazepine (PBOX-6) in leukaemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-xl J Pharmacol Exp Ther 310 3 2004 1084 1095
38. D.G. Kirsch, A. Doseff, B.N. Chau, D.S. Lim, N.C. de Souza-Pinto, and R. Hansford et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c J Biol Chem 274 30 2009 21155 21161
39. B. Zhang, I. Gojo, and R.G. Fenton Myeloid cell factor-1 is a critical survival factor for multiple myeloma Blood 99 6 2002 1885 1893 (Pubitemid 34525465)
40. S.H. Kaufmann, J.E. Karp, and P.A. Svingen Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse Blood 91 3 1998 991 1000 (Pubitemid 28078303)
41. R.W. Stam, M.L. Den Boer, and P. Schneider Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia Blood 115 5 2010 1018 1025
42. C. Pepper, T.T. Lin, and G. Pratt Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers Blood 112 9 2008 3807 3817
43. S. Kitada, J. Andersen, and S. Akar Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses Blood 91 9 1998 3379 3389 (Pubitemid 28193890)
44. R.P. Wong, S. Khosravi, M. Martinka, and G. Li Myeloid leukemia-1 expression in benign and malignant melanocytic lesions Oncol Rep 19 4 2008 933 937 (Pubitemid 351802662)
45. R. Beroukhim, C. Mermel, D. Porter, G. Wei, S. Raychaudhuri, and J. Donovan The landscape of somatic copy-number alteration across human cancers Nature 46 7283 2010 899 905
46. B.J. Lestini, K.C. Goldsmith, M.N. Fluchel, X. Liu, N.L. Chen, and B. Goyal et al. Mcl-1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists Cancer Biol Ther 8 16 2009 1587 1595
47. I.E. Wertz, S. Kusam, C. Lam, T. Okamoto, W. Sandoval, and D.J. Anderson et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Nature 471 7336 2011 110 114
48. J.U. Amman, C. Haag, H. Kasperczyk, K.M. Debatin, and S. Fulda Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NFkB inhibition Int J Cancer 124 2009 1301 1311
49. K. Bettayeb, D. Baunbæk, C. Delehouze, N. Loaëc, A.J. Hole, and S. Baumli CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells Genes Cancer 1 4 2010 369 380
50. S.N. Willis, L. Chen, G. Dewson, A. Wei, E. Naik, and J.I. Fletcher et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins Genes Dev 19 11 2005 1294 1305 (Pubitemid 41003019)
51. T. Teitz, T. Wei, M.B. Valentine, E.F. Vanin, J. Grenet, and V.A. Valentine Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nat Med 6 5 2000 529 535 (Pubitemid 30305902)
52. S.W. Tait, and D.R. Green Mitochondria and cell death: outer membrane permeabilization and beyond Nat Rev Mol Cell Biol 11 9 2010 621 632
53. K.S. Ferreira, C. Kreutz, S. Macnelly, K. Neubert, A. Haber, and M. Bogyo Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes Apoptosis 17 5 2012 503 515
54. S.R. Walker, M. Chaudhury, E.A. Nelson, and D.A. Frank Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling Mol Pharmacol 78 5 2010 903 908